Index of reports
> Cases with Stevens-Johnson Syndrome (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Triazolam where reactions include stevens-johnson syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Triazolam side effects in female
Reported by a physician from Japan on 2012-06-19
Patient: female
Reactions: LIP Swelling, Eyelid Oedema, Eye Discharge, Scab, Pyrexia, Erythema, LIP Erosion, C-Reactive Protein Increased, Conjunctival Hyperaemia, Dizziness, Oral Mucosa Erosion, Erythema Multiforme, Blister, Stevens-Johnson Syndrome, White Blood Cell Count Increased, Papule, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lamictal
Dosage: 50mg per day
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-05
Triazolam
Dosage: .125mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-28
End date: 2012-05-05
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-04-21
End date: 2012-04-26
Possible Triazolam side effects in female
Reported by a physician from Japan on 2012-06-08
Patient: female
Reactions: LIP Swelling, C-Reactive Protein Increased, Dizziness, Rash, White Blood Cell Count Increased, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Triazolam
Dosage: .125mg per day
Administration route: Oral
Start date: 2012-03-28
End date: 2012-05-05
Lamictal
Dosage: 25mg per day
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2012-04-21
End date: 2012-04-26
Lamictal
Dosage: 50mg per day
Administration route: Oral
Start date: 2012-04-27
End date: 2012-05-05
Possible Triazolam side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-30
Patient: 72 year old male
Reactions: Dyspnoea, Rhabdomyolysis, Pyrexia, Rash, Erythema, Mucosal Erosion, Malaise, Disease Recurrence, Interstitial Lung Disease, Oral Mucosa Erosion, Oxygen Saturation Decreased, Stevens-Johnson Syndrome, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Triazolam
Dosage: per oral
Administration route: Oral
End date: 2011-08-04
Doral
Dosage: per oral
Administration route: Oral
End date: 2011-08-04
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2011-08-02
End date: 2011-08-03
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Gout
Start date: 2011-08-02
End date: 2011-08-03
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2011-07-01
End date: 2011-07-04
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Gout
Start date: 2011-07-01
End date: 2011-07-04
Allopurinol
Dosage: (100 mg) per oral
Administration route: Oral
Start date: 2011-07-01
End date: 2011-08-04
Zolpidem Tartrate
Other drugs received by patient: Folic Acid; Betamethasone; Metolate (Methotrxate); Arcrane (Sodium Alginate); Etisedan (Etizolam)
Possible Triazolam side effects in 72 year old male
Reported by a individual with unspecified qualification from Japan on 2011-10-28
Patient: 72 year old male
Reactions: Rhabdomyolysis, Interstitial Lung Disease, Decreased Appetite, Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doral
End date: 2011-08-04
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Gout
Start date: 2011-07-01
End date: 2011-07-04
Feburic (Febuxostat)
Dosage: 10 mg (10 mg,1 in 1 d) per oral ; 10 mg (10 mg,1 in 1 d) per oral
Administration route: Oral
Indication: Gout
Start date: 2011-08-02
End date: 2011-08-04
Triazolam
Dosage: per oral
Administration route: Oral
End date: 2011-08-04
Zolpidem Tartrate
Allopurinol
Dosage: 100 mg (100 mg) oral
Administration route: Oral
Start date: 2011-07-01
End date: 2011-08-04
Other drugs received by patient: Betamethasone; Metolate (Methotrexate); Arcrane (Sodium Alginate); Etisedan (Etizolam); Folic Acid
|